×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北京... [9]
复旦大学上海医学院 [4]
武汉大学 [3]
中南大学 [2]
紫金山天文台 [2]
上海天文台 [1]
更多...
内容类型
期刊论文 [17]
会议论文 [4]
发表日期
2018 [11]
2017 [3]
2016 [2]
2012 [5]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共21条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
期刊论文
LANCET, 2018, 卷号: 392, 期号: 10159
作者:
James, Spencer L. G.
;
Abate, Degu
;
Abate, Kalkidan Hessen
;
Abay, Solomon M.
;
Abbafati, Cristiana
收藏
  |  
浏览/下载:80/0
  |  
提交时间:2019/12/05
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
期刊论文
LANCET, 2018, 卷号: 392, 期号: 10159
作者:
Kyu, Hmwe Hmwe
;
Abate, Degu
;
Abate, Kalkidan Hassen
;
Abay, Solomon M.
;
Abbafati, Cristiana
收藏
  |  
浏览/下载:60/0
  |  
提交时间:2019/12/05
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017
期刊论文
LANCET, 2018, 卷号: 392, 期号: 10159
作者:
Roth, Gregory A.
;
Collaborotors, G. B. D.Causes Death
;
Abate, Degu
;
Abate, Kalkidan Hassen
;
Abay, Solomon M.
收藏
  |  
浏览/下载:79/0
  |  
提交时间:2019/12/05
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017
期刊论文
The Lancet, 2018, 卷号: 392, 期号: 10159, 页码: 1736-1788
作者:
Roth, Gregory A.*
;
Abate, Degu
;
Abate, Kalkidan Hassen
;
Abay, Solomon M.
;
Abbafati, Cristiana
收藏
  |  
浏览/下载:75/0
  |  
提交时间:2019/12/03
Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017
期刊论文
The Lancet, 2018, 卷号: 392, 期号: 10159, 页码: 1789-1858
作者:
James, Spencer L. G.
;
Abate, Degu
;
Abate, Kalkidan Hessen
;
Abay, Solomon M.
;
Abbafati, Cristiana
收藏
  |  
浏览/下载:53/0
  |  
提交时间:2019/12/03
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
期刊论文
LANCET, 2018, 卷号: 392, 期号: 10159
作者:
Kyu, Hmwe Hmwe
;
Abate, Degu
;
Abate, Kalkidan Hassen
;
Abay, Solomon M.
;
Abbafati, Cristiana
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2019/12/05
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
期刊论文
LANCET, 2018, 卷号: 392, 期号: 10159
作者:
James, Spencer L. G.
;
Abate, Degu
;
Abate, Kalkidan Hessen
;
Abay, Solomon M.
;
Abbafati, Cristiana
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2019/12/05
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017
期刊论文
LANCET, 2018, 卷号: 392, 期号: 10159
作者:
Roth, Gregory A.
;
Collaborotors, G. B. D.Causes Death
;
Abate, Degu
;
Abate, Kalkidan Hassen
;
Abay, Solomon M.
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2019/12/05
Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer
期刊论文
2018, 卷号: 13, 期号: 10, 页码: 1539-1548
作者:
Wu, Yi-Long
;
Lu, Shun
;
Lu, You
;
Zhou, Jianying
;
Shi, Yuan-kai
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2020/01/03
ALK-positive advanced non-small cell lung cancer
crizotinib
chemotherapy
phase III
Long-term safety of crizotinib in previously treated patients (pts) with ALK-positive advanced/metastatic non-small cell lung cancer (NSCLC)
期刊论文
2018, 卷号: 29
作者:
Crino, L.
;
Ahn, M-J.
;
Han, J-Y.
;
Liu, X.
;
Ou, S-H. I.
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
©版权所有 ©2017 CSpace - Powered by
CSpace